Top NASDAQ 100 stocks to watch in August: DLTR, VRTX, EXC, COST, and TSLA

Be the First to Comment Read

Top NASDAQ 100 stocks to watch in August: DLTR, VRTX, EXC, COST, and TSLA

Follow us on Google News:
 Top NASDAQ 100 stocks to watch in August: DLTR, VRTX, EXC, COST, and TSLA
Image source: ©2022 Kalkine Media®

Highlights:

  • DLTR stock returned gains of over 70 per cent YoY.
  • Vertex (NASDAQ: VRTX) is due to report its Q2 FY22 earnings on August 4.
  • Tesla, Inc.'s (NASDAQ: TSLA) revenue jumped 42 per cent YoY in Q2 FY22.

US stocks seem to have come under pressure this year due to red-hot inflation and the Fed's aggressive efforts to rein it in under its two per cent target. Amid this, some investors seem to be on the lookout for stocks that are gaining despite market uncertainty, like Dollar Tree Inc. (NASDAQ: DLTR), Vertex Pharmaceuticals (NASDAQ: VRTX) etc.

Let's discuss some such stocks from the Nasdaq 100 index that have largely traded n the green on a year-over-year (YoY) basis.

Dollar Tree Inc. (NASDAQ: DLTR)

The US$38.62-billion market cap firm's stock rose 71 per cent YoY.  The discount store operator recently announced an executive leadership addition, naming Bobby Aflatooni as its new Chief Information Officer (CIO).

The Virginia-based firm reported in its first-quarter earnings that it saw its consolidated net sales jump 6.5 per cent YoY to US$6.90 billion in Q1 FY22. 

Dollar Tree's net income soared 43.2 per cent YoY to US$536.4 million in the latest quarter, while its diluted earnings per share (EPS) rose 48.1 per cent YoY to US$2.37.

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)

The US$71.68-billion market cap entity's stock returned 40.9 per cent gains YoY and closed at US$280.29 on July 22.

In Q1 FY22, Vertex's total product revenue rose 22 per cent YoY to US$2.09 billion, while its GAAP net income soared 17 per cent YoY to US$1.04 billion.

The biotech firm recently announced that it is planning to take its oral selective NaV1.8 inhibitor VX-548 forward into Phase 3 clinical trials in Q4 2022. 

In addition, it has also reached an agreement for designing the program with the US Food and Drug Administration (FDA). The FDA has reportedly greenlit the Breakthrough Therapy Designation of VX-548 for treating moderate-to-severe acute pain.

Exelon Corporation (NASDAQ: EXC)

The energy provider returned gains of 33.6 per cent YoY. With a market cap of US$43.14 billion, Exelon holds a price-to-earnings (P/E) ratio of 16.61, which denotes the value of a firm by measuring its current stock price relative to its earnings per share (EPS).

Exelon's operating revenue stood at US$5.32 billion in Q1 FY22, up from that of  US$4.63 billion in the same quarter of the prior year. Its net income was US$598 million in the latest quarter against a net loss of US$264 million in Q1 FY21.

With a current dividend yield of 3.13 per cent, Exelon pays an annualized dividend of US$1.35, which could draw the attention of income-focused investors.

Costco Wholesale Corporation (NASDAQ: COST)

The big-box retail store operator has largely traded in the red this year amid the broader market downturn. However, on a YoY basis, its stock value rose 25.16 per cent.

COST stock closed at US$529.72 on July 22, bringing its market cap to over US$234.64 billion and its P/E ratio to 41.71.

Costco currently distributes an annualized dividend of US$3.6. On July 13, its board announced a quarterly cash dividend of US$0.9, which is set to be payable on August 12.

Costco reported net sales of US$22.78 billion in June 2022, up 20.4 per cent from US$18.92 billion in the same month of the prior year. In Q3 2022, Costco's total revenue was US$52.59 billion and its net income was US$1.35 billion.

5 Top NASDAQ 100 stocks and their YoY return (in per cent)

Source: ©Kalkine Media®; © Arthon meekodong via Canva.com

Tesla, Inc. (NASDAQ: TSLA)

Tesla, Inc. (NASDAQ: TSLA) saw its stock close at US$816.73 on July 22, bringing its market cap to US$846.45 billion.

TSLA stock has lost over 31 per cent of its stock value this year. However, the EV stock remained in the positive territory on a YoY basis, gaining 24.19 per cent. 

The EV maker's total revenue soared 42 per cent YoY to US$16.93 billion in Q2 FY22, while its GAAP net income rose 98 per cent YoY US$2.25 billion.

Following its latest financial results, TSLA stock grew about 13 per cent in the last week.

Bottom line

The S&P 500 index fell 9.29 per cent YoY, while declining 16.88 per cent on an annual basis. On the other hand, the Nasdaq Composite Index declined 19.41 per cent YoY, while slipping 24.36 per cent year-to-date (YTD).

Nasdaq 100 index also witnessed a similar performance as the Nasdaq index. It fell 17.03 per cent YoY, and 24.04 per cent YTD.

Disclaimer

Featured Articles